Prasun K. Jalal MD
Hepatology & Liver Transplantation
Stan and Sue Partee Chair in Hepatology, Abdominal Transplant Center, Baylor College of Medicine
Join to View Full Profile
6620 Main StSte 1475Houston, TX 77030
Phone+1 713-798-8100
Fax+1 713-798-4530
Dr. Jalal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Prasun Jalal is a gastroenterologist in Houston, TX and is affiliated with multiple hospitals in the area, including Ben Taub General Hospital, Baylor St. Luke's Medical Center, and CHI St. Luke's Health-The Woodlands Hospital. He received his medical degree from Postgraduate Institute of Medical Education and Research, India and has been in practice 25 years. He specializes in hepatology & liver transplantation and is experienced in hepatology, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis due to chronic viral hepatitis, and cirrhosis due to autoimmune hepatitis. He has more than 50 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2006 - 2007
Zucker School of Medicine at Hofstra/NorthwellFellowship, Gastroenterology, 2003 - 2006
Royal College of Physicians, London, United KingdomFRCP, 1996 - 2001- Postgraduate Institute of Medical Education and Research, IndiaClass of 1994, MD
Certifications & Licensure
TX State Medical License 2008 - 2026
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- FRCP (London, UK), FACG, FASSLD, FASGE, AGAF
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Publications & Presentations
PubMed
- 2 citationsComparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort Study.Francisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, Winston Dunn, Heer Mehta
Alimentary Pharmacology & Therapeutics. 2025-04-01 - Moderate alcohol-associated hepatitis: A real-world multicenter study.Francisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, Heer Mehta, Karen Muñoz
Hepatology Communications. 2025-04-01 - Efficacy and Safety of 10-Day Versus 14-Day Bismuth-Containing Quadruple Therapy forEradication: A Systematic Review and Meta-Analysis.Najam Gohar, Zoya Ejaz, Faizan Ahmed, Abdul Rafay Ahmed, Muhammad Abdullah Humayun
JGH Open. 2025-03-01
Press Mentions
Tapering Corticosteroids in Severe Alcohol-Associated Hepatitis Appears SafeNovember 28th, 2024
Heart Health Symposium Focuses on Asian Indian Risk of Heart Attacks and Its PreventionDecember 14th, 2017- IDA Hosts Fundraiser in Aid of Indian IDC Charity ClinicDecember 7th, 2017
Grant Support
- CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASEBAYLOR COLLEGE OF MEDICINE2024–2026
- Intestinal Microbiota Transplantin Severe Alcohol associated HepatitisNatinal Institute of Health2022–Present
- Early Diagnosis of Liver CancerDora Roberts FoundationPresent
- MacDonald Research GrantBaylor St Luke Medical CenterPresent
Committees
- Education and Scholarship Committee, International Liver Transplantation Society
- Program Evaluation Committee, American Association for the Study of Liver Disease
Professional Memberships
- Fellow
- Fellow
- Fellow
- Member
- American Association for the Study of Liver DiseaseFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
